Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Outcomes of cystic fibrosis pulmonary exacerbations treated with antibiotics with activity against anaerobic bacteria

Journal of Cystic Fibrosis(2021)10.1016/j.jcf.2021.02.001Source: DataRank Database

Outcomes of cystic fibrosis pulmonary exacerbations treated with antibiotics with activity against anaerobic bacteria is a research paper published in Journal of Cystic Fibrosis (2021). On theSindex it has a DataRank of 0. It has been cited 9 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access9 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 0.91)OA: bronzeTopics (44)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (5)

Madsen Zimbric ORCID,Shannon Cahalan ORCID,Corey Powell ORCID,Lindsay J. Caverly ORCID,Lauren M. Castner ORCID

Live enrichment

PubMed:33612403 PMC:PMC8371065 OpenAlex:https://openalex.org/W3133050888

National Institutes of Health

Grant: K23HL136934

Cystic Fibrosis Foundation

Grant: CAVERL17A0

FWCI

0.91

Citation Percentile

0.7%

Citation Trend

2021

2022

2023

2024

2025

2026

bronzeLicense: http://www.elsevier.com/open-access/userlicense/1.0/

journalhttp://www.cysticfibrosisjournal.com/article/S1569199321000369/pdf

publisherhttp://www.cysticfibrosisjournal.com/article/S1569199321000369/pdf

publisherhttps://api.elsevier.com/content/article/PII:S1569199321000369?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1569199321000369?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.jcf.2021.02.001

Fields of Study

Cystic Fibrosis Research AdvancesNosocomial Infections in ICUSinusitis and nasal conditionsAdministration, IntravenousAdolescentAdultAnti-Bacterial AgentsBacteria, AnaerobicCystic FibrosisFemaleForced Expiratory VolumeHumansMaleRetrospective StudiesSymptom Flare Up

MeSH Terms

Symptom Flare UpAdolescentAdultAnti-Bacterial AgentsBacteria, AnaerobicCystic FibrosisFemaleForced Expiratory VolumeHumansMaleRetrospective StudiesAdministration, Intravenous

Keywords

Cystic fibrosisAntibioticsMedicineAnaerobic exerciseAnaerobic bacteriaInternal medicineMicrobiologyPseudomonas aeruginosaObligate anaerobeRetrospective cohort studySingle CenterGastroenterologyBacteriaBiologyPhysiologyExacerbationsAnaerobes

Sustainable Development Goals

SDG 0: Good health and well-being